The First Wave of AI-Driven Clinical Workflow Optimization
Keywords:
Artificial intelligence in healthcare,Clinical workflow optimization,AI adoption in clinical settings,Early-stage AI implementation,Healthcare process automation,Clinical decision support systems,Machine learning in healthcare operations,Workflow efficiency improvement,AI-driven clinical productivity,Health information systems integration,Clinical operations management,Digital transformation in healthcare,Care delivery optimization,Provider workload reduction,AI impact on clinical practice.Abstract
Early artificial intelligence (AI) adoption and a weakness in organizational execution represent two elements that shape practical examples of AI-assisted clinical workflow optimization. Some institutions are realizing operational efficiencies, short-term reductions in clinical error rates, and enhanced patient experience even amid talent shortages. Initial improvements align with the actual diagnostic or treatment pathway being executed and the real-world clinical and technical capabilities enabled by the AI initiative. Data-driven medicine on the other hand, with its call for evidence-based, structured data-driven access to clinical decision support tools at the time and place of need, as well as automated alerts and reminders, remains a vision yet to be fully realized. Institutions with the right elements in place can expect workflow enhancements provided clinicians are willing and able to trust their clinical judgment more than the underlying models and embrace delegation.
While some hospitals have implemented data-mature and user-centered data-driven medicine for the first three years for diagnostic support and decision-making, AI-supported routing and triage, multispecialty treatment planning, and high-urgency multidisciplinary approval have remained aspirational. In other words, the implementation readiness of AI-supported workflow optimization in these hospitals remains in flux, with elements switching between enablers and barriers. Expectation alignment, however, has improved markedly during the same period. Work that focuses on the evolution of clinical governance, data infrastructure, training needs across clinician groups, user-centered design, and operating model readiness is therefore directly relevant to translating AI ambition into execution.
References
1. Bajwa, J., Munir, U., Nori, A., & Williams, B. (2021). Artificial intelligence in healthcare: Transforming the practice of medicine. Future Healthcare Journal, 8(2), e188–e194.
2. van der Laak, J., Litjens, G., & Ciompi, F. (2021). Deep learning in histopathology: The path to the clinic. Nature Medicine, 27, 775–784.
3. McIntosh, C., Conroy, L., Tjong, M. C., Craig, T., Bayley, A., Catton, C., Gospodarowicz, M., Helou, J., Isfahanian, N., Kong, V., Lam, T., Raman, S., Warde, P., Chung, P., Berlin, A., & Purdie, T. G. (2021). Clinical integration of machine learning for curative-intent radiation treatment of patients with prostate cancer. Nature Medicine, 27, 999–1005.
4. Inala, R. (2023). Revolutionizing Customer Master Data in Insurance Technology Platforms: An AI and MDM Architecture Perspective. International Journal of Finance (IJFIN)-ABDC Journal Quality List, 36(6), 579-606.
5. Yin, J., Ngiam, K. Y., & Teo, H. H. (2021). Role of artificial intelligence applications in real-life clinical practice: Systematic review. Journal of Medical Internet Research, 23(4), e25759.
6. Ghassemi, M., Oakden-Rayner, L., & Beam, A. L. (2021). The false hope of current approaches to explainable artificial intelligence in health care. The Lancet Digital Health, 3(11), e745–e750.
7. Knop, M., Weber, S., Mueller, M., & Niehaves, B. (2022). Human factors and technological characteristics influencing the interaction of medical professionals with artificial intelligence-enabled clinical decision support systems: Literature review. JMIR Human Factors, 9(1), e28639.
8. Lam, T. Y. T., Cheung, M. F. K., Munro, Y. L., Lim, K. M., Shung, D., & Sung, J. J. Y. (2022). Randomized controlled trials of artificial intelligence in clinical practice: Systematic review. Journal of Medical Internet Research, 24(8), e37188.
9. El-Kareh, R., & Sittig, D. F. (2022). Enhancing diagnosis through technology: Decision support, artificial intelligence, and beyond. Critical Care Clinics, 38(1), 129–139.
10. Aravind, R., Surabhi, S. N. D., & Shah, C. V. (2023). Remote Vehicle Access: Leveraging Cloud Infrastructure for Secure and Efficient OTA Updates with Advanced AI. EuropeanEconomic Letters (EEL), 13 (4), 1308–1319. Retrieved fromhttps.
11. Gonzalez-Smith, J., Shen, H., Singletary, E., et al. (2022). How health systems decide to use artificial intelligence for clinical decision support. NEJM Catalyst Innovations in Care Delivery, 3(4).
12. Davenport, T., & Kalakota, R. (2022). The potential for artificial intelligence in healthcare. Future Healthcare Journal, 9(2), 94–98.
13. Inala, R. (2023). Big Data Architectures for Modernizing Customer Master Systems in Group Insurance and Retirement Planning. Educational Administration: Theory and Practice, 29(4), 5493-5505.
14. Topol, E. J. (2022). The future of medicine is in our hands: AI, data, and the transformation of healthcare. Nature Medicine, 28, 1–3.
15. Grote, T., & Berens, P. (2022). On the ethics of machine learning in medicine. Journal of Medical Ethics, 48(9), 629–634.
16. Yu, K. H., Beam, A. L., & Kohane, I. S. (2022). Artificial intelligence in healthcare. Nature Biomedical Engineering, 6, 719–731.
17. Klement, J., El Emam, K., & Choudhury, O. (2022). Artificial intelligence and machine learning in healthcare: Challenges and opportunities for clinical implementation. NPJ Digital Medicine, 5, 1–9.
18. Topol, E. (2022). Deep medicine: How artificial intelligence can make healthcare human again. Basic Books.
19. Meskó, B., & Görög, M. (2023). A short guide for medical professionals in the era of artificial intelligence. NPJ Digital Medicine, 6, 1–6.
20. Nuutinen, M., & Leskelä, R.-L. (2023). Systematic review of the performance evaluation of clinicians with or without the aid of machine learning clinical decision support system. Health and Technology, 13, 557–570.
21. Akay, E. M. Z., Hilbert, A., Carlisle, B. G., Madai, V. I., Mutke, M. A., & Frey, D. (2023). Artificial intelligence for clinical decision support in acute ischemic stroke: A systematic review. Stroke, 54(6), 1505–1516.
22. Joyce, D. W., Kormilitzin, A., Smith, K. A., & Cipriani, A. (2023). Explainable artificial intelligence for mental health through transparency and interpretability for understandability. NPJ Digital Medicine, 6, Article 6.
23. Wang, D., Yang, Q., Abdul, A., & Lim, B. Y. (2023). Designing theory-driven user-centric explainable AI for clinical decision support. Proceedings of the ACM on Human-Computer Interaction, 7(CSCW1), 1–28.
24. Chen, I. Y., Joshi, S., Ghassemi, M., & Dullerud, G. E. (2023). Probabilistic machine learning for healthcare: Challenges and opportunities. Nature Medicine, 29, 1–10.
25. Siontis, K. C., Noseworthy, P. A., Attia, Z. I., & Friedman, P. A. (2023). Artificial intelligence-enhanced electrocardiography in cardiovascular disease management. Nature Reviews Cardiology, 20, 1–14.
26. Aitha, A. R. (2021). Dev Ops Driven Digital Transformation: Accelerating Innovation In The Insurance Industry. Journal of International Crisis and Risk Communication Research.
27. Kelly, C. J., Karthikesalingam, A., Suleyman, M., Corrado, G., & King, D. (2021). Key challenges for delivering clinical impact with artificial intelligence. BMC Medicine, 19, Article 195.
28. Sendak, M. P., D'Arcy, J., Kashyap, A., Gao, M., Nichols, M., Corey, K., & Balu, S. (2021). A path for translation of machine learning products into healthcare delivery. EMJ Innovations, 5, 1–9.
29. Yang, G., Ye, Q., & Xia, J. (2022). Unbox the black-box for the medical explainable AI via multi-modal and multi-centre data fusion: A mini-review, two showcases and beyond. International Journal of Medical Informatics, 153, 104541.
Additional Files
Published
Issue
Section
License
Copyright (c) 2024 Luca Bianchi (Author)
This work is licensed under a Creative Commons Attribution 4.0 International License.
The American Online Journal of Science and Engineering (AOJSE) is an open-access journal, and all published articles are made freely available to readers worldwide under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license governs the use, sharing, adaptation, and distribution of all content published in AOJSE and is designed to promote the broadest possible dissemination and reuse of scholarly research.
Creative Commons Attribution 4.0 International License (CC BY 4.0)
Under the Creative Commons Attribution 4.0 International License, any user is free to share, copy, and redistribute the published material in any medium or format, and to adapt, remix, transform, and build upon the material for any purpose, including commercial use, provided that appropriate credit is given to the original authors and source. The license cannot be revoked as long as the terms are followed.
When using or redistributing content published in AOJSE, users must provide proper attribution by citing the original authors' names, the article title, the journal name (AOJSE), the volume and issue number, the year of publication, and the DOI or URL of the article. Users must also indicate if any changes were made to the original work. Attribution must be provided in a reasonable manner but must not suggest that the authors or AOJSE endorse the user or their use of the material.
Author Rights and Copyright Retention
AOJSE respects and upholds the intellectual property rights of all contributing authors. Authors who publish in AOJSE retain full copyright over their work. By submitting a manuscript to AOJSE, authors grant the journal a non-exclusive, worldwide, royalty-free license to publish, reproduce, distribute, publicly display, and archive the article in print and electronic formats. This license allows AOJSE to make the article freely accessible to readers globally while ensuring that the authors remain the rightful owners of their work.
Authors are permitted to deposit their published articles in institutional repositories, personal websites, academic networking platforms, and preprint servers, provided that the original publication in AOJSE is acknowledged and properly cited. Authors may also reuse their published content in subsequent works, presentations, teaching materials, and grant applications without requiring prior permission from the journal.
Third-Party Content
Authors are solely responsible for obtaining written permission to reproduce any third-party material, including figures, tables, images, data, or excerpts from other publications, included in their manuscript. Evidence of such permissions must be provided to the editorial office upon request. AOJSE does not assume any responsibility for copyright infringement arising from the unauthorized inclusion of third-party content in published articles.
Permitted Uses
Under the CC BY 4.0 license, the following uses of AOJSE published content are freely permitted without prior written permission from the journal or authors, provided that proper attribution is given. Users may read, download, print, and distribute articles for personal, educational, or research purposes. Researchers may reuse data, figures, and findings for meta-analyses, systematic reviews, and secondary research. Educators may incorporate published articles into course materials, syllabi, and academic presentations. Journalists, policymakers, and practitioners may reference and cite published findings for professional and public interest purposes.
Prohibited Uses
While the CC BY 4.0 license is broad and permissive, users may not apply legal terms or technological measures that legally restrict others from doing anything the license permits. Users may not misrepresent the original authorship of published content or imply endorsement by the original authors or AOJSE without explicit consent. Plagiarism, data fabrication, and any form of academic misconduct in the reuse of published material are strictly prohibited and are a violation of publication ethics standards.
Institutional and Repository Deposit Policy
AOJSE fully supports self-archiving and green open access. Authors are encouraged to deposit the final published version of their article, also known as the version of record, in institutional repositories, subject repositories, and open-access databases immediately upon publication. There is no embargo period. Authors should always link back to the original article on the AOJSE website and include the full citation and DOI when depositing their work in any repository.
Digital Preservation and Archiving
AOJSE is committed to the long-term digital preservation of all published content to ensure its permanent availability and accessibility. The journal utilizes the Open Journal Systems (OJS) platform, which supports internationally recognized digital archiving standards. AOJSE encourages participation in archiving networks such as LOCKSS (Lots of Copies Keep Stuff Safe) and CLOCKSS (Controlled LOCKSS) to safeguard published articles against data loss and ensure continued access for future generations of researchers and readers.
Disclaimer
The views, opinions, findings, and conclusions expressed in articles published in AOJSE are solely those of the authors and do not necessarily reflect the official position, policy, or views of the journal, its editorial board, or its affiliated organizations. AOJSE makes every effort to ensure the accuracy and integrity of published content but does not accept legal responsibility for any errors, omissions, or claims arising from the use of information published in the journal.
Contact for Licensing Inquiries
For any questions regarding the licensing terms, copyright, or permitted use of content published in AOJSE, please contact the editorial office through the journal website at https://aojse.org. The editorial team will be happy to assist authors, readers, and institutions with any licensing-related queries.
